advertisement
Eye 55
Showing records 1 to 25 | Display all abstracts in Eye104786 Ophthalmic surgery in New Zealand: analysis of 410,099 surgical procedures and nationwide surgical intervention rates from 2009 to 2018
Hossain RR
Eye 2023; 37: 1583-1589
104452 Combined phacoviscocanalostomy versus phacoemulsification alone in patients with coexisting cataract and mild-to-moderate open-angle glaucoma; a randomized-controlled trial
Zarei R
Eye 2023; 37: 1390-1396
104882 Surgical outcomes of excisional goniotomy using the kahook dual blade in severe and refractory glaucoma: 12-month results
Bravetti GE
Eye 2023; 37: 1608-1613
104501 The risk of retinal vein occlusion among patients with neovascular age related macular degeneration: a large-scale cohort study
Weinstein O
Eye 2023; 37: 1445-1450
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Hu X
Eye 2023; 37: 607-617
104348 The current use of glaucoma virtual clinics in Europe
Azzopardi M
Eye 2023; 37: 1350-1356
105034 Risk of acute angle-closure and changes in intraocular pressure after pupillary dilation in patients with diabetes
Xiong K
Eye 2023; 37: 1646-1651
104882 Surgical outcomes of excisional goniotomy using the kahook dual blade in severe and refractory glaucoma: 12-month results
Gillmann K
Eye 2023; 37: 1608-1613
104348 The current use of glaucoma virtual clinics in Europe
Prokosch-Willing V
Eye 2023; 37: 1350-1356
104786 Ophthalmic surgery in New Zealand: analysis of 410,099 surgical procedures and nationwide surgical intervention rates from 2009 to 2018
Guest S
Eye 2023; 37: 1583-1589
104452 Combined phacoviscocanalostomy versus phacoemulsification alone in patients with coexisting cataract and mild-to-moderate open-angle glaucoma; a randomized-controlled trial
Azimi A
Eye 2023; 37: 1390-1396
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Zhang B
Eye 2023; 37: 607-617
104452 Combined phacoviscocanalostomy versus phacoemulsification alone in patients with coexisting cataract and mild-to-moderate open-angle glaucoma; a randomized-controlled trial
Azimi A
Eye 2023; 37: 1390-1396
105034 Risk of acute angle-closure and changes in intraocular pressure after pupillary dilation in patients with diabetes
Wang L
Eye 2023; 37: 1646-1651
104501 The risk of retinal vein occlusion among patients with neovascular age related macular degeneration: a large-scale cohort study
Kridin M; Kridin K
Eye 2023; 37: 1445-1450
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Li X
Eye 2023; 37: 607-617
104452 Combined phacoviscocanalostomy versus phacoemulsification alone in patients with coexisting cataract and mild-to-moderate open-angle glaucoma; a randomized-controlled trial
Fakhraei G
Eye 2023; 37: 1390-1396
105034 Risk of acute angle-closure and changes in intraocular pressure after pupillary dilation in patients with diabetes
Li W
Eye 2023; 37: 1646-1651
104882 Surgical outcomes of excisional goniotomy using the kahook dual blade in severe and refractory glaucoma: 12-month results
Salinas L
Eye 2023; 37: 1608-1613
104786 Ophthalmic surgery in New Zealand: analysis of 410,099 surgical procedures and nationwide surgical intervention rates from 2009 to 2018
Wallace HB
Eye 2023; 37: 1583-1589
104348 The current use of glaucoma virtual clinics in Europe
Michelessi M
Eye 2023; 37: 1350-1356
104501 The risk of retinal vein occlusion among patients with neovascular age related macular degeneration: a large-scale cohort study
Mann O
Eye 2023; 37: 1445-1450
104348 The current use of glaucoma virtual clinics in Europe
Fea AM
Eye 2023; 37: 1350-1356
105034 Risk of acute angle-closure and changes in intraocular pressure after pupillary dilation in patients with diabetes
Wang W
Eye 2023; 37: 1646-1651
104452 Combined phacoviscocanalostomy versus phacoemulsification alone in patients with coexisting cataract and mild-to-moderate open-angle glaucoma; a randomized-controlled trial
Eslami Y
Eye 2023; 37: 1390-1396
